Pharmacopoeia language lists low-MW peptides plus vitamins and microelements. Mixture of sequences. Synthetic companion is cortagen (AEDP).
Archive identity for a polypeptide fraction. Mixture of sequences.
Key takeaways
Cortexin is a Morozov-protocol polypeptide fraction from pig or cow cerebral cortex, one of the Khavinson-adjacent products with wider Russian clinical adoption outside gerontology alone.
Mapped themes include carotid-occlusion / preconditioning animal work, mollusk neuron biophysics of the peptide-glycine combination, glaucoma series, and stroke / ischemia clinical titles on PubMed.
It is a mixed fraction. Cortagen (AEDP) is the defined-sequence companion on this shelf.
What it is
Cortexin is the cerebral-cortex polypeptide fraction: low-molecular-weight peptides with pharmacopoeia co-components (amino acids, vitamins, microelements) in Russian product descriptions.
School electrophysiology writing contrasts peptides alone with the registered peptide-glycine combination on neuron membrane behaviour.
We keep it because it is one of the denser Russian neurology and ophthalmology trails among secondary bioregulators.
What the literature describes
Themed chapters drawn only from papers already mapped on this dossier. Archive map. No medical advice.
Ischemia, preconditioning, and neuroprotection frames
Russian full text includes titles on cortexin neuroprotective effects and ischemic preconditioning, plus long experience of low-dose peptide neuroprotection reviews. PubMed indexes stroke rehabilitation, hemispheric ischemic stroke quality-of-life, and intravenous versus intramuscular dosage-form equivalence titles.
A CyberLeninka title pairs neuronoprotective action of cortexin and cortagen. Synthesis notes that in Planorbarius neurons the peptide-glycine combination hyperpolarises, while peptides alone mildly activate.
Russian titles cover cortexin in glaucoma and unstabilised glaucoma. PubMed includes young patients with glaucoma associated with myopia among haemodynamic and metabolic correction papers.
influence of cortexin on the level of neurotrophic protein s100 in chronRussian full text
7 in corpus
Also on PubMed
2025[Therapeutic equivalence of intravenous and intramuscular dosage forms of Cortexin in ischemic strokes]. doi:10.17116/jnevro202512512160PubMed
2019[Treatment of a neglect syndrome in movement rehabilitation of stroke patients]. doi:10.17116/jnevro201911903129PubMed
2017[The administration of neurocytoprotectors in a rat model of experimental spinal cord ischemia]. doi:10.17116/jnevro20171176142-46PubMed
2016[EFFECT OF CORTEXIN ON THE QUALITY OF LIFE IN THE EARLY REHABILITATIVE PERIOD AFTER HEMISPHERIC ISCHEMIC STROKE].PubMed
2013[Cognitive disorders and their correction in patients with ischemic stroke].PubMed
2012[Efficacy of reflexology in the combination with neuroprotective treatment in hemiparetic form of children cerebral palsy].PubMed
2011[Medical treatment for correction of hemodynamic, rheological and metabolic changes in young patients with glaucoma associated with myopia].PubMed
7 curated · cytoflavin-perspective row removed as off-focus for cortexin
Still open
Which fraction components are necessary for the glycine-combination neuron effect?
How should acute ischemic stroke titles be read against chronic ischemia series?
What independent replication exists outside Russian Federation clinical networks?
Reviewed against the archive corpora on 2026-09-19. Source-grounded. No clinical claims. Archive / history / research only. No medical advice. No dosing, synthesis, sourcing, or health claims.